BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9382401)

  • 1. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia.
    Warkentin TE; Elavathil LJ; Hayward CP; Johnston MA; Russett JI; Kelton JG
    Ann Intern Med; 1997 Nov; 127(9):804-12. PubMed ID: 9382401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome.
    Warkentin TE; Cook RJ; Sarode R; Sloane DA; Crowther MA
    Blood; 2015 Jul; 126(4):486-93. PubMed ID: 25979950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis.
    Warkentin TE
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):589-93. PubMed ID: 11601930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
    Smythe MA; Warkentin TE; Stephens JL; Zakalik D; Mattson JC
    Am J Hematol; 2002 Sep; 71(1):50-2. PubMed ID: 12221676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia.
    Srinivasan AF; Rice L; Bartholomew JR; Rangaswamy C; La Perna L; Thompson JE; Murphy S; Baker KR
    Arch Intern Med; 2004 Jan; 164(1):66-70. PubMed ID: 14718324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene.
    Warkentin TE
    J Thromb Haemost; 2018 Nov; 16(11):2128-2132. PubMed ID: 30099843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia.
    Warkentin TE
    Transfus Med Rev; 1996 Oct; 10(4):249-58. PubMed ID: 8899954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
    Warkentin TE; Whitlock RP; Teoh KH
    Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin-induced limb gangrene in the setting of lung adenocarcinoma.
    Klein L; Galvez A; Klein O; Chediak J
    Am J Hematol; 2004 Jun; 76(2):176-9. PubMed ID: 15164386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management.
    Warkentin TE
    Drug Saf; 1997 Nov; 17(5):325-41. PubMed ID: 9391776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2000 Jul; 6(4):343-51. PubMed ID: 10912644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia.
    Warkentin TE; Sikov WM; Lillicrap DP
    Am J Hematol; 1999 Sep; 62(1):44-8. PubMed ID: 10467275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium heparin-induced immunologic thrombocytopenia complicated with venous gangrene of the legs. Report of a clinical case].
    Perfetto F; Chessa GC; Petri I; Cammilli A
    Ann Ital Med Int; 2001; 16(3):179-84. PubMed ID: 11692908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice.
    Raskob GE; George JN
    Ann Intern Med; 1997 Nov; 127(9):839-41. PubMed ID: 9382408
    [No Abstract]   [Full Text] [Related]  

  • 16. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Bartholomew JR
    Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of conventional treatment options for heparin-induced thrombocytopenia.
    Warkentin TE
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):17-25; discussion 35-6. PubMed ID: 9855180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian malignancy unmasked by venous gangrene in a patient on warfarin therapy: a case report.
    Said A; Keasberry J
    J Med Case Rep; 2016 Jun; 10(1):151. PubMed ID: 27264137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.